Harald Holte
Impact in
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 167
- Genetics 46
- Chronic Lymphocytic Leukemia Research 37
- Co-authors
- Stein KvaløyJan DelabieErlend B. SmelandEva KimbySophie D. FossåOle NomeArne KolstadAlexander Fosså
In The Last Decade
Harald Holte
243 papers receiving 6.4k citations
Peers
Comparison fields: 5 of 135
- Pathology and Forensic Medicine 3.8k
- Genetics 1.3k
- Oncology 3.2k
- Neurology 971
- Immunology 1.3k
Countries citing papers authored by Harald Holte
This map shows the geographic impact of Harald Holte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Holte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Holte more than expected).
Fields of papers citing papers by Harald Holte
This network shows the impact of papers produced by Harald Holte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Holte. The network helps show where Harald Holte may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Harald Holte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 4 | |
| 4 | 2021 | 18 | |
| 5 | 2021 | 17 | |
| 6 | 2021 | 71 | |
| 7 | 2019 | 82 | |
| 8 | 2019 | 22 | |
| 9 | 2019 | 39 | |
| 10 | 2019 | 18 | |
| 11 | 2017 | 28 | |
| 12 | 2012 | 386 | |
| 13 | 2011 | 41 | |
| 14 | 2010 | 34 | |
| 15 | Dose-dense induction followed by autologous stem cell transplant (ASCT) leads to sustained remissions in a large fraction of patients with previously untreated peripheral t-cell lymphomas (PTCLS) - overall and subtype-specific results of a phase II study from the nordic lymphoma group | 2009 | 20 |
| 16 | [Should alternative therapists treat cancer--what is the opinion of oncology health personnel?]. | 2003 | 0 |
| 17 | 2000 | 1 | |
| 18 | 1996 | 3 | |
| 19 | 1996 | 26 | |
| 20 | 1993 | 11 |
About Harald Holte
Harald Holte is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Neurology and Immunology, having authored 248 papers that have together received 6.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (167 papers), Chronic Lymphocytic Leukemia Research (37 papers), Viral-associated cancers and disorders (36 papers), CAR-T cell therapy research (34 papers), CNS Lymphoma Diagnosis and Treatment (33 papers), Immune Cell Function and Interaction (30 papers), Acute Lymphoblastic Leukemia research (17 papers) and Monoclonal and Polyclonal Antibodies Research (16 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.8k citations), Genetics (1.3k citations), Oncology (3.2k citations), Neurology (971 citations) and Immunology (1.3k citations). Harald Holte has collaborated with scholars based in Norway, Sweden and Denmark. Frequent co-authors include Stein Kvaløy, Jan Delabie, Erlend B. Smeland, Eva Kimby, Sophie D. Fosså, Ole Nome, Arne Kolstad, Alexander Fosså, Trond Stokke and Bjørn Østenstad. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Acta Oncologica and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.